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ABSTRACT 
 
 Nanotechnology has led to the development of novel applications and materials incorporated 
into consumer products known as nano-enabled products (NEPs). Consequently, the wide-spread use 
of NEPs has led to a concern of human exposure to constituent engineered nanomaterials (ENMs) 
utilized in the consumer products. This growing public health issue is largely due to limited safety 
regulations imposed on manufacturers and a lack of hazard characterization of NEP exposures to 
understand the human health implications. This in vitro study focused on NEPs such as aerosolized 
cosmetics, which are becoming more mainstream within the general population. A large majority of 
constituent ENMs such as metal nanoparticles (NPs) that are heavily used in the cosmetic industry 
have been associated with asthma, inflammation, and other pulmonary conditions upon exposure. 
Within this study, we utilized a novel aerosol exposure system to monitor and sample released 
nanoparticle (rNP) aerosols from two separate cosmetic lines to determine potential differences in 
manufacture or production. The exposure system consisted of a stainless-steel glove box containing a 
mannequin head with fitted outlet sample portals that allowed monitoring of aerosols using scanning 
mobility particle sizer (SMPS). To generate cosmetic aerosols, an automated nebulizer controlled by 
proprietary software that controlled spray durations, length of exposures, and aerosol concentrations 
was fitted in the glove box. The enclosed glove box system was pressurized using a vacuum while 
HEPA filtered air was used to regulate air flow (11 L/min) and aerosol release from the nebulizer. 
The generated aerosols or rNPs were sampled or collected on to mixed cellulose ester (MCE) filters 
for subsequent aqueous extraction and off-line physico-chemical characterization of collected rNPs 
to determine particle morphology and elemental composition using scanning electron microscopy 
coupled with energy dispersive x-ray spectroscopy (SEM-EDS). Colloidal characterization was 
performed on extracted rNPs and pristine nanoparticles (pNPs) iron-oxide (Fe2O3) and titanium 
dioxide (TiO2), which are found in great quantities in each of the raw or whole cosmetics determined 
by inductively coupled plasma mass spectrometry (ICP-MS). The toxicological profiles of acute 24-
hour exposure to extracted rNPs and pNPs were then compared using human bronchial (16HBE) and 
primary small airway epithelial cells (SAEC) to model airway responses to NEP exposures. The 
results indicate that SAEC were most susceptible to exposure to rNPs than 16HBE. It was also 
determined that rNPs, specifically the darker shades of cosmetics induced higher levels of reactive 
oxygen species, oxidative stress, and cytotoxicity. Immunocytochemistry confirmed by western blot 
analysis of 3-week sub-chronic exposures to rNPs indicated epithelial mesenchymal transition 
(EMT), suggesting fibrotic changes in exposed SAEC. While further studies are needed to provide a 
more comprehensive picture of the effects of rNPs, this study has established findings that can be 
used towards future research regarding inhalation exposure to NEPs. Moreover, the findings indicate 
that susceptible populations such as darker skinned individuals or individuals with pre-existing 
conditions may be at higher risk to the adverse effects of NEP cosmetic exposures.
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1. INTRODUCTION 
Nanotechnology, or the synthesis and manipulation of materials that measure <100 
nanometers, is currently used in numerous industries to design or revamp products and 
applications to meet the continuing market demand for innovation and efficiency. Since the 
1980s, nanotechnology and the resulting nanomaterials have had beneficial uses in a wide array 
of fields, such as electronics, healthcare, environmental remediation, and in everyday products, 
such as fabrics, degreasers, baseball bats, tennis rackets, luggage, eyeglasses, food packaging, 
and camera lenses (United States National Nanotechnology Initiative, n.d.). While there have 
been recorded examples of premodern uses of nanotechnology, evidence of production of 
consumer nano-enabled products (NEPs) has been present in the marketplace since around 1999 
(United States National Nanotechnology Initiative, 2014). Since then, the need for better, 
cheaper, and stronger products, as well as motive for increasing production, profit, and 
reliability, has scaled up the use of nanomaterials. 
  In 2007, the National Science Foundation estimated that $70 billion of NEPs were sold 
annually in the United States alone (Rice University, 2007). In 2013, it was estimated that there 
was $1 trillion in global revenue from NEPs and it is projected that nanotechnology will have a 
market value of $4.4 trillion by 2018 (Lux Research, 2014; NSF, 2014). There is currently a 
working list of consumer products that contain nanomaterials called the Woodrow Wilson 
Nanotechnology Consumer Products Inventory (CPI) (Vance et al., 2015). The CPI has 
information on over 1,600 manufacturer-identified nanotechnology-based consumer products 
that have been released into the market within the last twenty years (Vance et al., 2015). While 
this provides some helpful insight as to characteristics and details about some of these products, 
new products and formulations are being continually released, along with various permeations of 
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nanomaterials and regulations, that makes it difficult to track the most up-to-date and accurate 
number of NEPs being distributed globally. What poses an additional hurdle in the quest to 
identify the number of NEPs in the market is that manufacturers are not required to label their 
products that are composed of nanomaterials (Kessler, 2011). While, as recently as 2017, the 
U.S. Environmental Protection Agency (EPA) has tried to regulate nanomaterials under the 
Toxic Substances Control Act, it does not include all the existing nanomaterials and only 
requires “premanufacture notifications for new nanomaterials” (US EPA, 2015a). This one-time 
reporting and recordkeeping of existing exposure and health and safety information on 
nanomaterial exposure is an attempt to understand them in commerce (US Department of 
Commerce, 2018; US EPA, 2015b). Over time, this regulation may allow the EPA to obtain 
more information from the manufacturers about these products, but as NEP production continues 
to skyrocket, this will pose little-to-no safety presently for consumers who may potentially be 
exposed to these products daily without knowing it.  
While use of nanotechnology in products does provide some promising benefits, such as 
improved drug delivery systems and drinking water treatment, both the acute and chronic 
adverse effects are largely unknown, especially concerning personal consumer NEPs, such as 
sunscreens, toothpaste, shampoos, lotions, and cosmetics (Adeleye et al., 2016; Kessler, 2011; 
Valavanidis & Vlachogianni, 2016). These products contain engineered nanomaterials (ENMs) 
that are designed or tailored for a specific purpose by varying physicochemical properties, such 
as chemical composition, small particle sizes, solubility, aggregation, and structures (Nel, Xia, 
Mädler, & Li, 2006; Park et al., 2017). Because of these unique properties that can be 
manipulated, ENMs are considerably more variable and unknown than naturally-occurring 
ambient nanoparticles.  
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ENM exposure can be primary or direct contact with the cell, where the ENMs elicit 
responses related to toxicity, DNA damage, inflammation, or oxidative stress, or secondary, such 
as causing inflammation in various body systems and alterations in organ functions (Armstead & 
Li, 2016; Nel et al., 2009; Nurkiewicz et al., 2011; Pal et al., 2015; Schrand, Dai, Schlager, & 
Hussain, 2012; Song et al., 2011; C. Watson et al., 2014; Watson, DeLoid, Pal, & Demokritou, 
2016). Nanoparticles are known to have the ability to cross blood-brain, blood-testis, and blood-
placental barriers, delaying risk assessment and regulations could have adverse effects on future 
generations and epigenetics (Lim, Baeg, Srinivasan, Dheen, & Bay, 2017; Martirosyan & 
Schneider, 2014; Miura & Shinohara, 2009). 
 Nanoparticles can take five main routes of exposure: inhalation, ingestion, ocular, 
dermal, and intravenous, also known as nanomedicine. The route of greatest concern to the 
public is the inhalation route because it is the most common route occupational workers and 
consumers are exposed to most frequently. It is easy for dry, airborne ENMs to mimic gas 
particles and agglomerate in the air and be transported further to various parts of the body (Yokel 
& MacPhail, 2011). When airborne particles containing ENMs are inhaled, these particles can 
settle in various regions of the respiratory tract depending on their size. Larger, more 
agglomerated particles tend to settle in the upper respiratory areas, such as the nasal cavity, 
which smaller particles can penetrate lower into the pulmonary regions of the respiratory tract.  
Given each of the pathways, ENMs can ultimately migrate to the circulatory system and settle in 
various organs, such as liver, however, if the gastrointestinal (GI) tract or nasal cavity is exposed 
to ENMs, they can alternatively migrate to the lymphatic system or brain, respectively (Yokel & 
MacPhail, 2011). Inhaled ENMs have been observed to have similar characteristics to known 
disease-causing agents, such as asbestos, particulate matter (PM), and silica, which warrant the 
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need for further research on the biological activity of ENMs after inhalation (Bunderson-
Schelvan, Holian, & Hamilton, 2017). 
Inhalation exposure is the most studied and has been linked to cardiorespiratory and 
mortality, especially since there can be large particles mixed in cities with high pollution (Kelly 
& Zhu, 2016; Miller et al., 2017). With ENMs being able to be deposited so compactly deep into 
the lungs and cause oxidative stress, it has been thought to have been linked to inflammation and 
breathing problems but also more serious disease outcomes such as asthma, airway and lung 
fibrosis, and cancer (Donaldson et al., 2005; Miller, Shaw, & Langrish, 2012; Nikota et al., 2016; 
Poulsen et al., 2015; Ryman-Rasmussen et al., 2009). It has also been suggested that 
nanoparticles may be able to translocate and circulate throughout the body and accumulate in 
organs, such as the liver and heart, and be associated with cardiovascular disease (Hirn et al., 
2011; Husain et al., 2015; Miller et al., 2017; Mills et al., 2009; Oberdörster et al., 2002). ENMs 
have also been observed to trigger macrophages due to inflammation events in the lungs, which 
suggest that ENMs can cause cellular damage and may trigger specific activation sites for 
immune response (Huang et al., 2017; Tsugita, Morimoto, & Nakayama, 2017; C. Y. Watson et 
al., 2015). Though not all knowledge is known for inhalation exposure to ENMs, potential 
adverse effects can be based on existing knowledge of toxicological outcomes of inhaled 
particles or substances (Nikota et al., 2016; Puzyn, Leszczynska, & Leszczynski, 2009). 
ENMs may be contained in products in a fixed form, which keeps the nanoparticles in 
place and tends to have a low potential to be released, and a free form, which has the highest risk 
of exposure to the public, as these are the nanoparticles found in everyday consumer products, 
such as cosmetics, food, and medicines (Boxall et al., 2007). The release of ENMs may depend 
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on concentration, frequency, and amount administered and researchers believe that the majority 
of the release will happen with consumer end-use, as opposed to during manufacturing (Boxall et 
al., 2007). The released airborne nanoparticles (rNPs) found in NEPs can function differently 
than the same pristine nanoparticles (pNPs) found in bulk as their toxicological, biologically, and 
chemical properties can change and they can be mixed with solvents or create volatile organic 
compounds (VOCs) or other compounds upon release (Nazarenko et al., 2011). In particular, 
added stabilizers, such as surfactants, polymers, and thiols have been observed to increase the 
mobility of nanoparticles (Boxall et al., 2007; Tungittiplakorn, Lion, Cohen, & Kim, 2004). Both 
these added chemicals and the form the consumer product is created in (e.g. whether it is a 
applied powder, liquid, or spray) can affect agglomeration of these particles, as well as 
chemically modifying them (Nazarenko et al., 2011). As products are modified, this can change 
the magnitude of effects ENMs have on humans as opposed to when humans are exposed to 
pNPs. pNPs have mainly been characterized, as opposed to rNPs, partially due to the fact that 
there are complex methods that need to be developed for testing (which can be time consuming 
and costly), deficits in knowledge of how they are prepared in NEPs, and uncertainties with dose 
metrics (Becker, Herzberg, Schulte, & Kolossa-Gehring, 2011). However, there are a few studies 
that have characterized aerosolized nanoparticle releases from NEPs (Nazarenko et al., 2011; 
Nazarenko, Zhen, Han, Lioy, & Mainelis, 2012; Pal, Watson, et al., 2015; D. Singh et al., 2017). 
It has been observed that there is a decrease in cellular viability that is found with increasing 
doses of smaller particles, which is not observed as readily with larger particles using the same 
delivered dose (Pal, Watson, et al., 2015; Watson-Wright, Singh, & Demokritou, 2017). In 
plastics that have metal oxides (such as TiO2) or iron additives (such as Fe2O3) added, the 
emission of  polycyclic aromatic hydrocarbons (PAHs) increased significantly after combustion 
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compared to plastics without these components (D. Singh et al., 2017; Watson-Wright et al., 
2017).  In cosmetic powders, the rNPs were determined to be delivered into both head airways 
and alveolar regions and can be delivered to all other regions of human respiratory system in 
agglomerates that vary in size and, when mixed with other ingredients and aerosolized, can affect 
distribution and potential toxic effects (Nazarenko et al., 2011, 2012). These results show the 
importance and need for understanding ENM transport mechanisms, dosimetry, comprehensive 
toxicological profiles, and interactions with different cell lines while updating and validating 
various toxicological testing methodology and realistic inhalation simulations in concert.  
 One of the potential disease outcomes related to ENM exposure is asthma. It has been 
observed that oxidative stress has a key role in pathogenesis of asthma by factors, such as 
causing increased airway inflammation and fibrotic changes in lung tissue and decreased 
defenses against oxidative stress in the form of antioxidants (Cho & Moon, 2010; Sahiner, 
Birben, Erzurum, Sackesen, & Kalayci, 2011). There is strong evidence that shows that ENMs 
(particularly those containing metals) create free radicals and thus can lead to either beginning or 
worsening allergic responses (Ihrie & Bonner, 2018; Johnson, Mendoza, Raghavendra, Podila, & 
Brown, 2017; Pal, Bello, Budhlall, Rogers, & Milton, 2011). This can be especially important 
when pertaining to applied consumer products, such as cosmetics, as factors, such as race, 
gender, location, diet, and socioeconomic status (SES) can all play a part in possibly magnified 
effects due to oxidative stress. For example, darkly-pigmented cosmetics aimed at being used by 
predominately African Americans or other darker races might contain more metal ENMs, such as 
Fe2O3, to provide more color to the product. This, in turn, can more adversely affect them due to 
racial differences in lung functions, decreased levels of antioxidants, and higher levels of 
oxidative stress and thus make African Americans a more susceptible population (Harik-Khan, 
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Muller, & Wise, 2004; Morris et al., 2012). Cheaper NEPs might also have different chemical 
formulations with various levels of ENMs, which could also make people that have low SES a 
more susceptible population. Other factors, such as sex differences, living in a highly polluted 
area, and diets low in antioxidants may contribute to higher risk to adverse effects due to ENM 
exposure (Cabello et al., 2015; Schulz et al., 2015; Shvedova et al., 2016; Sonane, Moin, & 
Satish, 2017). 
 To address current knowledge gaps regarding the safety of NEPs and potential human 
inhalation exposures to released nanoparticles (rNPs), we utilized human primary small airway 
epithelial cells (SAEC) and human SV40-immortalized bronchial epithelial cells (16HBE). 
These cell types are being utilized to assess how rNPs may have differing effects depending on 
their size and how they settle in the upper or lower respiratory tract. SAEC are more sensitive, 
reside the distal portion of the lungs and regulate immune responses through chemokines while 
16HBE have been used a model to study the cystic fibrosis transmembrane conductance 
regulator (CFTR), reside in the bronchial walls form tight junctions and play a role in ion 
transport (Cozens et al., 1994; Crystal, Randell, Engelhardt, Voynow, & Sunday, 2008; Jiang, 
Malavia, Suresh, & George, 2009). Various toxicological assays were used to determine the 
impact of both pNP and rNP exposures. The pNPs were obtained in bulk and the rNPs were 
obtained using a custom-made exposure system by IEStechno to simulate real-world exposure 
scenarios and provide rNPs from NEPs to perform accurate toxicological assessments. A light 
and a dark shade of two brands of airbrush foundation makeup were selected as the NEPs known 
to have various rNPs, such as iron (III) oxide (Fe2O3) and titanium dioxide (TiO2), as a part of its 
chemical formulation. The airbrush kit was assembled and collected in the exposure system for 
20 minutes for each product, thoroughly cleaned after each use according to manufacturer 
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instructions. The SAEC and 16HBE were exposed for 24 hours to either pristine Fe2O3, TiO2, or 
rNPs before assays were conducted. Cellular viability was examined using the MTS cell 
proliferation assay while oxidative stress and produced reactive oxygen species (ROS) were 
measured using the CellRox® Orange and total glutathione (GSH) assays. Differing levels of 
proteins were visualized using the immunocytochemistry (ICC) fluorescent assay and western 
blots were performed to visualize upregulation and downregulation of proteins involved in the 
epithelial–mesenchymal transition (EMT) pathway. The proposed hypothesis for this thesis is 
that the rNPs have higher toxicity profiles due to the adsorption of chemical additives than pNPs. 
With this data collected, this could suggest that rNPs, especially those that pose inhalation 
exposure risks, could warrant both more of a hazard to human and environmental health than 
pNPs alone and an even higher risk for vulnerable populations. 
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2. REVIEW OF THE LITERATURE  
 
2.1 Evolution of Nanotechnology and Nanotoxicology 
 The terms “nanotechnology” and “nanomaterials” are becoming increasingly more 
important as more nanomaterial-containing chemicals are being manufactured. Not much is 
known about the mechanisms, distributions, toxicity to humans and the environment, or even 
potential therapeutic properties of nanomaterials, however, toxicological methodologies and 
technologies are rapidly advancing in detecting these substances. Nanomaterials are 
characterized as ultrafine particles that are <0.1µm in diameter (Hodgson, 2010). The smaller the 
diameter of a substance, the more toxicity increases, as these particles can reach more regions in 
the body and deposit in clusters. Nanomaterials can either be naturally occurring (ambient) or 
manufactured by man (ENMs). Ambient nanoparticles have varying shapes, compositions, and 
sizes while ENMs are uniform compounds (Hood, 2004).  Ambient nanoparticles tend to be 
found in urban areas and near highways and their concentrations can fluctuate based on certain 
factors, such as traffic patterns, amounts of smoke and exhaust released, and seasons, while 
ENMs are manufactured and have a more controlled and consistent concentration. Ambient 
nanoparticles have been found to be mainly composed of silicon, carbon, oxygen, nitrogen, and 
sulfur while ENMs can consist of a wider range of elements (Johnston et al., 2013). With more 
elements introduced, it could potentially pose a wider array of risks on human health and could 
complicate analysis of specific health effects on future generations.  
 
2.2 Engineered Nanomaterial Uses 
 ENMs are useful in a variety of sectors such as automotive, electronics, chemical and 
material industries, agriculture, energy, health and pharmaceuticals, biomedical, environmental, 
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metals and plastics, product safety, and cosmetics (Ostiguy & IRSST (Québec), 2010). One of 
the more popular uses for ENMs using silver nanoparticles (AgNPs) to improve fabric 
sterilization, water purification, and wound dressing, as compared to bulk silver (Musee, Thwala, 
& Nota, 2011). It also acts as an antibacterial agent because it is effective at protecting against 
fungi and antibiotic resistant strains of bacteria, such as Streptococcus sp (Musee et al., 2011). 
Other ENMs with antibacterial characteristics include carbon fullerenes (C60), zinc oxide (ZnO), 
TiO2, and single-walled carbon nanotubes (SWCNT) (Musee et al., 2011). These bacteria 
inhibiting properties found in these and other ENMs can be useful in the biomedical industry, 
such as being used to lower the viral load of HIV in HIV+ patients and protect the cells from 
apoptosis (Sun et al., 2005). There continues to be more applications found for ENMs for other 
public health problems, which, while could have some positive outcomes, could also 
unintentionally introduce chronic exposure to unknown levels of these materials in the 
environment and in humans using various mechanisms. 
 
2.3 Routes of Exposure 
 As described in the introduction, there are five routes of exposure ENMs take, with the 
most pertinent route being inhalation. Another route of exposure ENMs take is through 
ingestion. Currently, little is known about adverse effects due to oral ingestion and the 
bioavailability of ENMs under the tongue (sublingual site) or mouth (buccal cavity) but the 
gastrointestinal (GI) tract does absorb some ENMs in areas where the gastric epithelial cells are 
compromised or where there is a low concentration of mucin (Yokel & MacPhail, 2011). 
Absorption into the GI tract depends on the size of the ENMs and the smaller ENMs are more 
likely to be absorbed more readily. A couple of in vivo fish studies have observed uptake of 
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AuNPs and cerium dioxide (CeO2) into the GI tract via ingestion of ENMs at a size of 25 and 35 
nm, respectively (Gaiser et al., 2009, 2011). By aquatic species biologically taking up and 
storing these ENMs in their tissues, this could potentially be a cause of concern for humans via 
exposure through eating fish or other related foods.  
 Ocular exposure can happen with airborne ENMs and can occur intentionally or 
unintentionally. Intentional exposure happens when cosmetics that contain ENMs are placed near 
the eye and unintentional exposure happens with chemical splashes in the eyes or transfer of 
ENMs off hands by rubbing eyes, which has been observed to happen to approximately 37% of 
adults per hour (Hendley, Wenzel, & Gwaltney, 1973). Through this route of exposure, ENMs 
can gain access inside of the body through the cornea into the eye or it can be drained into the 
nasal cavity (Yokel & MacPhail, 2011). There have been only a couple of studies that have 
researched the effects of nanoparticles on the ocular system, particularly ambient nanoparticles 
present in the ozone, and these studies have observed that graphene oxide (GO) and airborne 
TiO2 have observed reversible eye damage via oxidative stress and ocular surface damage, 
respectively (Eom et al., 2016; Wu et al., 2016). Possible therapeutic interventions using ocular 
injections of various drugs containing nanoparticles are being examined for safety and toxicity 
(Mehra, Cai, Kuo, Hein, & Palakurthi, 2016). 
 Dermal exposure has also been studied very little and this type of exposure is observed to 
provide little harm because the skin serves as an impassible primary barrier to foreign agents 
and, thus, can protect the body from these potentially harmful agents. However, these materials 
may pass through the top layer of the outermost epidermis, known as the stratum corneum, into 
the second or third layer, known as the stratum granulosum and stratum spinosum, respectively. 
If ENMs penetrate these layers of the epidermis, there is little protection offered and these 
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materials may be absorbed by the circulatory and lymphatic system and may produce an immune 
response by triggering keratinocytes to release pro-inflammatory cytokines (Gopee et al., 2007). 
Consumer materials that may put the public at risk for dermal exposure include quantum dots, 
titania, gold, silver, and zinc oxides that are found in sunscreens, cosmetics, and other topical 
agents applied directly to the skin (Brouwer et al., 2016; Cao, Li, Tang, Chen, & Zhao, 2016). 
Drug carrier and delivery has also been studied for dermal effects due to ENM exposure but little 
is still known about the effects of delivering nanoparticle-based drugs through intact skin 
(Lademann et al., 2013). More research can also be done in determining risk of harmful effects 
from unintentional occupational dermal exposure (Brouwer et al., 2016).  
 Nanomedicine, or internally introducing nanomaterials intentionally inside of the body, is 
an up-and-coming technique that is gaining utilization in medical research and health care 
settings.  This can involve performing Intra-peritoneal (IP) or intravenous (IV) injections of 
nanoparticles to deliver a drug that will circulate throughout the system or that can deposit into 
an organ, such as the liver, or can even target tumors (Armstead & Li, 2016). By injecting the 
nanoparticles directly into the body, it can bypass normal absorption processes but may 
accumulate in tissues and organs (Zhao & Castranova, 2011). One study looked at how intra-
articular injected cobalt chromium (CoCr) affected male rats’ reproductive systems and observed 
increases in abnormal sperm and testicular damage and physiological changes possibly due to 
oxidative stress (Wang et al., 2013). Another study looked at the same nanoparticle but injected 
peri-articular in mice to observe if there was a genotoxic effect or immune reaction and found 
that there was increased DNA damage in bone marrow, a heightened sensitivity to nickel and 
chromium, and more mice developed a Th1 driven response (Brown et al., 2013). Nanoparticles 
partnered with biodegradable polymers have also been studied as well to help increase blood 
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circulation and reduce deposition in the liver (Gref et al., 1994). Another revolutionary 
functionality discovered is nanocarriers that can be used for cancer treatments with a lower 
solubility than current treatment options to help effectively bind and specifically target cancerous 
cells (Luo et al., 2012; Peer et al., 2007). Nanoparticles have also been utilized in burn wards and 
have aided in sealing wounds and keeping out bacteria in severe burns (Jahromi et al., 2017). 
Quantum dots can also be used in diagnostic imaging used for more precise medical diagnoses 
(De Silva, 2007). Many aspects of nanomedicine could be explored to help revamp current 
medicine and medical practices to help treat public health related issues, but possibly negative 
implications could also come from using nanoparticles without conducting more toxicological 
testing.   
These other routes of exposure taken by ENMs are important because they can also cause 
morbidity. For example, dermal exposure can lead to skin sensitization, which may translate to 
possible changes in absorption and disposition of the ENMs through the skin and into the body 
(Heylings et al., 1996; S. Smulders, Golanski, Smolders, Vanoirbeek, & Hoet, 2015). Ingestion 
of ENMs can lead to interruption of internal microbiota in the GI tract and inflammatory diseases 
(Bouwmeester, van der Zande, & Jepson, 2017; van den Brule et al., 2016). Ocular exposure to 
ENMs runs the risk of expressing reversible irritation and inflammation in the eye and cervical 
lymph nodes as well after multiple acute durations of exposure (Eom et al., 2016; Wu et al., 
2016). Little is known about the long-term effects of direct injections of ENMs into whole-body 
systems but they are known to accumulate in various organs and tissues and increased immune 
response (Brown et al., 2013; Stijn Smulders et al., 2016). More research should be conducted on 
all routes of exposure to be able to accurately characterize the continuum of risks associated with 
ENM exposure to human and environmental health. 
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2.4 Inhalation Mechanisms of Engineered Nanomaterial Exposure 
 Since ENMs are have such a small diameter, they can penetrate deeper into the lungs, 
even into the distal lung region but still can deposit throughout the whole respiratory tract. They 
also tend to stick together and form agglomerates, which can create more surface area and be 
harder to dislodge them when breathing or coughing. The more time spent in the lungs, the more 
chance of causing adverse effects, such as generating ROS and oxidative stress. One upper 
respiratory clearance mechanism the human respiratory tract is equipped with is the mucociliary 
escalator, which is when mucous attempts to trap particles before they reach the alveoli to 
prevent damage (Hodgson, 2010).This escalator traps and pushes particles up into the trachea, 
where they can be swallowed and moved to the GI tract (Hodgson, 2010). This is the most 
common clearance method and transport depends on the amount of cilia and the lung lining layer 
(Kreyling & Scheuch, 2000) Another mechanism is lung phagocytosis, which can direct particles 
to the lymph, however, they can be stored there for a long residency period and it could cause 
damage (Hodgson, 2010). In clinical studies, nanoparticles have been observed to accumulate in 
the liver and spleen because of opsonization and the mononuclear phagocytic system (MPS) 
(Garcia et al, 2014). In fact, this has led to the development of zwitterionic-coatings to help make 
nanoparticles more biocompatible and reduce the risk of non-specific absorption of proteins or 
lipids (Pombo García et al., 2014). With further developments such as these, it can pave the way 
for nanoparticles to be used in more therapeutic manners and reduce side effects in 
individualized therapeutic interventions for a wide variety of diseases.  
 If the nanoparticles manage to sneak by the various innate clearance mechanisms, they 
may compromise lymphatic drainage, enter the blood stream, and disseminate into secondary 
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organs (Geiser & Kreyling, 2010). Since particle clearance kinetics in humans is extremely slow, 
this could mean that 10-20% of insoluble particles will never be cleared from the lungs and can 
be associated with potentially increased chances of fibrotic pathogenesis (Geiser & Kreyling, 
2010). Even if the particles are translocated to the larynx interstitium, they may still either be 
taken up by epithelial cells or relocate and end up back on the surface of the lungs (Geiser & 
Kreyling, 2010). In addition to these effects, nanoparticles can also cause premature cell death, 
increase instances of exocytosis, can generate more ROS, inflammation, etc. (Fröhlich, 2016). 
2.5 Pristine Nanoparticles Versus Real Exposure Methodologies 
 ENM exposure has typically been measured from pNPs, as compared to actual exposure, 
which can overestimate the harmful effects of ENMs (Pal, Watson, et al., 2015). By developing a 
protocol that follows the amount that is released and what can be captured based on the route of 
exposure, toxicological assessments can be conducted to get one step closer to developing dose-
response curves and determining perceived versus actual risk. Real-time monitoring, as well as 
integrated monitoring, of the rNPs are integral parts to measuring exposure because it can help 
develop a cause-effect association between release of these nanomaterials and exposure (Pal, 
Watson, et al., 2015). One framework that has been used is the sampling, extraction, dispersion, 
and dosimetry (SEDD) methodology (Pal, Watson, et al., 2015). In this frame work, total particle 
numbers, size, distribution, mass concentration, and other physical, chemical, and morphological 
characteristics must be determined first for the particles so that it can provide a better 
understanding of the sites where they deposit in the lungs when inhaled (Pal, Watson, et al., 
2015).This could be done using a vast array of equipment, including a water-based condensation 
particle counter to measure concentrations, both a scanning mobility particle sizer and an 
16 
 
aerodynamic particle sizer used to measure size distribution, a Q-track to measure environmental 
conditions during release, and a photo ionization-based system for measuring volatile organic 
compounds (VOCs) (Pal, Watson, et al., 2015).  
The next step is to extract the sampled particles from collection impaction substrates by 
using aqueous extractions for extraction efficiencies greater than 90% or ethanol extractions for 
extraction efficiencies less than 90% (Pal, Watson, et al., 2015). These masses are then weighed 
using a gravimetric analysis technique to determine the total amount collected and particle 
extraction efficiencies can be calculated. The third step in this framework is measuring 
dispersion and colloidal characterization suspended in a liquid, which is of great importance to 
accurately measure the size of the particles, charge, conductivity, and any possible agglomerate 
activity that may form, thus affecting the surface area and penetrability into the lungs (Pal, 
Watson, et al., 2015).   
Nanoparticle characterization of size and concentration can be measured using turnable 
resistance particle sizing (TRPS), which looks at changing ionic currents as the particles pass 
through a membrane with pores that have a certain nanometer size (Anderson, Kozak, Coleman, 
Jämting, & Trau, 2013; Kozak, Anderson, Vogel, et al., 2012; Kozak, Anderson, Grevett, & 
Trau, 2012; Pal et al., 2014).  Mode, mean, percent cell viability and percentages can be 
calculated using individual measurements (Anderson et al., 2013). After this step, the doses 
obtained from in vitro experiments should be adjusted for in vivo to account for varying 
parameters, such as rates of respiration and breathing patterns and frequency, so it can be more 
accurately generalizable to humans. The relative in vitro dose (RID) and toxic doses at 50 and 
90% (t50 and t90) can be calculated (Pal, Watson, et al., 2015) 
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The last step is to examine cell toxicity by studying toxicological or cellular responses, 
such as oxidative stress, cytotoxicity, and genotoxicity, as well as measuring the strength of the 
association of the dose-response curve (Pal, Watson, et al., 2015). This can be done using various 
in vitro assays that are commonly used in nanotoxicology, such as metabolic activity (MTS or 
MTT,  CellTiter 96® Aqueous One (Promega)), which determines the capacity of cell 
metabolism by introducing a soluble tetrazolium salt to the cells and observe if it is metabolized, 
and lactate dehydrogenase (LDH), which determines if damage has incurred to cellular 
membranes by fluorescing based on how much lactate has been released from the cytoplasm of 
the damaged or dead cells. MTS and LDH are inversely related to each other because MTS 
determines cellular viability while LDH determines irreversible cell death. Another common way 
to measure cellular viability is using trypan blue to stain the deceased cells and is not taken up in 
living, healthy cells (Hillegass et al., 2010). CellRox™ or ROS-Glo H2O2™  are assays used for 
analyzing the effects of oxidative stress on exposed cells using stains and luminescence, 
respectively, to identify upregulation or downregulation of proteins involved with membranous 
proteins (Peruzynska et al., 2017). The clonogenic assay (CFE) shows affects after exposure by 
measuring cell proliferation, survival, and colony behavior for several weeks (Herzog et al., 
2007). Other common assays to determine cytotoxicity include calcein AM, Live/Dead, alamar 
blue and neutral red (Hillegass et al., 2010). 
Assays can also be conducted for examination of genotoxicity and gene expression. Two 
popular assays conducted for genotoxicity include the Ames assay, which uses Salmonella 
typhimurium and Escherichia coli to determine if the nanoparticles can cause mutations in DNA 
and allow colonies to grow on histidine-free media, and the Comet assay, which uses a custom 
gel with pores between 20 and 40 microns to assess single or double stranded DNA breaks by 
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visualization of DNA damage using SYBR gold stain (Ames, Durston, Yamasaki, & Lee, 1973; 
C. Watson et al., 2014). Other genotoxic assays include chromosomal aberration introduction 
and micronuclei and using oxidized guanine bases to determine point mutations (Fung, Kow, 
Van Houten, & Mossman, 1997; Mori et al., 2006). Gene expression can be measured by 
Northern blots, polymerase chain reaction (PCR), and various microarrays (Hillegass et al., 
2010). 
2.6 Engineered Nanomaterial Hazard Characterization 
Various endpoints have been reported from hazard characterization from ENMs from 
oxidative stress, inflammation, genotoxicity, and cytotoxicity. For example, TiO2 has been 
classified as possibly carcinogenic to humans (Group 2B) after inhalation and intratracheal 
exposure and has observed increased inflammation, changes in signal transduction, reduced 
DNA methylation, and epigenetic changes (Chen, Yan, & Li, 2014; Shi, Magaye, Castranova, & 
Zhao, 2013; Stoccoro et al., 2017). Genotoxic, oxidative, and inflammatory effects were also 
observed in transformed alveolar cells when exposed and bronchial cells having an increased 
susceptibility to cytotoxic events (Ursini et al., 2014). Genotoxicity can also be due to direct 
DNA damage from particles or indirect interactions with ROS created from toxic ions released 
from the ENMs (Barnes et al., 2008; Kisin et al., 2007; A. Kumar & Dhawan, 2013). Other 
genotoxic endpoints have observed that ENMs are unlikely to induce micronuclei and were able 
to damage DNA (which was able to be viewed more easily with acute, short exposure times 
because there is less time for DNA to be repaired) and possible increased cell transformation 
(Stoccoro et al., 2017). Overall, it has been observed that increased inflammatory response can 
lead to cytotoxic effects, oxidative stress caused by ROS created by ENMs can alter cell growth, 
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change can occur in the immune system or macrophage recruitment system, and the large, 
complex surface area of the agglomerated particles can lead to DNA damage (Tolaymat, El 
Badawy, Sequeira, & Genaidy, 2015).  
Since there are currently many gaps in the knowledge about potentially harmful effects 
on humans and the environment from both ambient ENMs and NEPs, they are typically not 
evaluated in risk assessment (Handy, Owen, & Valsami-Jones, 2008; Klaine et al., 2012; 
Mitrano, Motellier, Clavaguera, & Nowack, 2015; Nowack & Bucheli, 2007). With more 
products being released on a daily basis without proper evidence of safety and health risks, the 
effects of ENMs in products could get more complicated with more variables, less certainty in 
associations, and aged throughout the products’ life cycles (Mitrano et al., 2015). As products get 
altered, this can change the magnitude of effects ENMs have on humans as opposed to when 
humans are exposed to pristine ENMs. This could also change the structure, potential toxicity 
and risks, and transformation of the ENMs depending on route of exposure. For example, when 
inhaled, more secondary particles created from aerosolized ENMs may have a different or worse 
toxic effect on humans. By changing the coating, size, surfaces, and more of ENMs, it can alter 
their behavior and cause unpredictable effects.  
2.7 Nano-enabled Products and Current Regulations 
 In 2007, the National Science Foundation estimated that $70 billion worth of NEPs were 
sold each year in the United States alone and manufacturers are not required to list ENMs on any 
products containing them (Bergeson et al., 2010; Kessler, 2011). In 2013, it was estimated that 
there was $1 trillion in global revenue from NEPs (NSF, 2014). Companies keep updating and 
changing various aspects of ENMs (there are at least 50,000 different types of SWCNT as of 
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2007) that make the need for research and regulation become more apparent (Schmidt, 2007). 
Currently, there is limited regulation for nanomaterials in the U.S. The United States 
Environmental Protection Agency (EPA) is trying to establish comprehensive regulatory 
activities and has tried to enact several control measures, such as limiting the use of nanoscale 
materials, requiring the use of personal protective equipment (PPE) when working with these 
particles, limiting environmental release, and requiring environmental and health tests to be done 
to determine how harmful these particles could be (US EPA, 2015b). Effective as of 2017, the 
EPA is requiring that there should be a one-time reporting and recordkeeping of existing 
exposure and health and safety information on nanomaterial exposure in an attempt to 
understand them in commerce (US EPA, 2015b). After data is collected, the EPA will then 
determine if any further measures are needed to address the use of nanomaterials. This could 
help control the use of nanoparticles down the road but, with the use of NEPs skyrocketing, 
regulations may not be able to keep up.  
 Regulations are important, not only because new products are being released, but old 
products are being reformulated with nanoparticles. While nanoparticles have been known to be 
present in paints, sunscreens, toothpaste, shampoos, lotions and cosmetics, it has also been found 
in edible products like food and dietary supplements (Kessler, 2011). Some of the food it is 
found in is chewing gum, salad dressings, candy and other sweets, and milk (Binh et al., 2015; 
Martirosyan & Schneider, 2014; Weir, Westerhoff, Fabricius, Hristovski, & von Goetz, 2012). 
There are currently a few studies that have made suggestions to guide a development of risk 
assessment in these food but still little is known or being done about the risks (Lim et al., 2017; 
Noonan, Whelton, Carlander, & Duncan, 2014; G. Singh, Stephan, Westerhoff, Carlander, & 
Duncan, 2014; Szakal et al., 2014). Even if there is little risk in ingesting or application of NEPs, 
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it can still get washed off in showers or excreted into waste water and runoff, which can affect 
freshwater ecosystems and other organisms that come in contact with the water (Binh et al., 
2015).  
 As of 2013, according to the research conducted by Vance et al., there 1814 consumer 
products from 622 companies in 32 countries that contain engineered nanomaterials (2015). 
About 30% of the products have been identified as containing nanomaterials suspended in liquid 
and most are intended to be used on the skin (Vance et al., 2015). Silver is the most used 
nanomaterial but almost half (49%) of products do not specify what nanomaterials are used in 
them (Vance et al., 2015). This reinforces the notion of the importance of swiftly continuing to 
characterize, test, and research ENMs and their potentially hazardous effects. 
SiO2, TiO2, and carbon nanotubules are some of the more common ENMs found in NEPs 
(Schmidt, 2007; Sotiriou et al., 2014). Since there are so many NEPs released, there are some 
studies researching toxicological testing mechanisms, as well as designing safer nanoparticles 
that can be used instead to keep performance high with less risk to the environment and human 
health (Pal, Watson, et al., 2015; Sotiriou et al., 2014). Particle size and characterization alone 
cannot determine toxicological risks of ENM exposure, as it is also dependent on how they are 
released, what secondary and tertiary byproducts are created, and the interaction of biomolecules 
and cells within the body (Becker et al., 2011; A. E. Nel et al., 2009). There has been a lack of 
identifying safety of ENM because of lack of reliable tests, interference of ENMs with reagents 
in tests, incorrect characterization of ENMs or unknown methods for ENM synthesis (Howard, 
2010; A. Kumar & Dhawan, 2013; Stone, Johnston, & Schins, 2009). Pristine nanomaterials 
have mainly been characterized, as opposed to released nanomaterials, partially due to the fact 
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that there are complex methods that need to be developed for testing (which can be time 
consuming and costly), deficits in knowledge of how they are prepared in NEPs, and 
uncertainties with dose metrics (Becker et al., 2011). However, there are a few studies that have 
characterized aerosolized nanoparticle releases and the results have indicated a need for further 
testing and characterization of the potential effects of released ENMs (Pal, Watson, et al., 2015; 
Vorbau, Hillemann, & Stintz, 2009). 
2.8 Impact of Engineered Nanomaterial Exposure on Body Systems 
Along with gaps in rNPs, gaps exist in knowing how ENMs affect body systems. 
However, there is some knowledge from physiological changes in the lungs, breasts, and brain. 
Adverse physiological effects in the lungs tend to be more prominent in small nanoparticles 
compared to their larger counterparts (Inoue et al., 2007). The lung tends to get mostly damaged 
by overproduction of ROS, lowering effectiveness of protective systems, and decreasing 
clearance by the mucociliary system (Inoue et al., 2007).  ENM exposure can also disrupt 
cardiovascular homeostatic or increase effects of cardiovascular disease (Mann, Thompson, 
Shannahan, & Wingard, 2012). Identified vascular changes, such as increased vascular 
permeability, loss of reactivity, and increased vasoconstricted states have also been reported 
(Mann et al., 2012).  
Epigenetic changes, genotoxic, and non-genotoxic effects have been observed in breast 
carcinoma tissue when exposed to quantum dots (Choi, Brown, Szyf, & Maysinger, 2008). 
ENMs have been observed to be possible endocrine disruptors or alter the endocrine system, 
which can contribute to fibrocystic disease of the breast and breast cancer (Iavicoli, Fontana, 
Leso, & Bergamaschi, 2013). Some nanoparticles are being used to aid in detecting breast cancer 
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cells, so doing further testing on the potential harms these can have on fatty tissues can aid in 
designing safer protocols for medical diagnoses and ambient exposure via all routes of exposure 
(C. S. S. R. Kumar, 2009).  
ENM exposure impacts on the brain and the central nervous system (CNS) has been 
rarely studied thus far and, while some therapeutic and diagnostic treatments have been 
established, there is the potential of oxidative stress, among other components, to have adverse 
effects (Oberdörster, Elder, & Rinderknecht, 2009; Suh, Suslick, Stucky, & Suh, 2009). ENMs 
can transport through the blood brain barrier, the brain’s protective shield, and settle in the CNS 
for an unknown amount of time and has been observed in testing dental resin, bonding systems, 
coatings on dentures, and other dental devices and substances composed of ENMs that are placed 
in close proximity to the brain (Feng et al., 2015). It has been observed that any contact with 
nanoparticles at higher doses, regardless of route of exposure, can result in significant uptake and 
exposure to fragile organs and systems, such as the CNS, and cause permanent damage (Minkel, 
2007; Oberdörster et al., 2009). The brain and related organs is especially sensitive to ROS and 
can cause morphological and cellular changes in microglia and other biological targets, which 
show implications of much needed research in potential substantial neurotoxic properties of 
ENMs (Long, Saleh, Tilton, Lowry, & Veronesi, 2006).  
2.9 Epithelial Mesenchymal Transition 
Epithelial mesenchymal transition (EMT) is a process of diversifying cells of various 
tissues. It occurs when epithelial cells lose their polarity and migrate and become multipotent 
mesenchymal stem cells. The mesenchymal cells have more migratory properties, invasiveness, 
and a higher risk for apoptosis (Kalluri & Neilson, 2003). Molecules involved in the initiation of 
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EMT are transcription factors, expression of specific cell-surface and cytoskeletal proteins, 
production of Extracellular Matrix (EMC) degrading enzymes, and changes in the expression of 
specific microRNAs (Kalluri & Neilson, 2003).  
There are three types of EMT that result in different severities of consequences. Type 1 
does not cause fibrosis or is invasive, so it spreads easily throughout the body and can generate 
secondary epithelia (Kalluri & Neilson, 2003). Type 2 is associated with wound healing, tissue 
regeneration, and fibrosis and, unlike type 1 EMTs, they are only present with inflammation, and 
can lead to persistent inflammation and eventual organ damage (Kalluri & Neilson, 2003). Type 
3 EMTs have undergone both epigenetic and genetic changes and favor overgrowth and creating 
tumors, which can lead to increased risk of developing many types of cancers (Kalluri & 
Neilson, 2003). EMT can cause cancer as it transforms cells, changes their morphology, 
increases motility and cell proliferation. Epithelial cells can also exhibit only a few 
characteristics of EMT, which can be considered partial EMT (Lamouille, Xu, & Derynck, 
2014). There is also changes in regulation of gene expression, where some proteins may get 
upregulated and some downregulated. Examples of transcription factors that are activated early 
on with the mesenchymal cell transformation is SNAIL, TWIST, and zinc-finger-E-box-binding 
(ZEB) (Lamouille et al., 2014). These can lead to changes in other protein regulation levels, 
translational and transcriptional players, expression of non-coding RNAs, protein stability, and 
splicing (De Craene & Berx, 2013).  
ROS also has been observed to act as a mediator to the EMT process (M. Li et al., 2016). 
However, many other factors can contribute to progression of EMT and can be further studied to 
gain more knowledge to prevent potential cancers and irreversible damage due to fibrosis or 
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other diseases. Currently, not too much is known about ENM exposure and its effect on EMT. 
However, one study showed that inhalation exposure to single-walled carbon nanotubes increase 
the incidence of K-ras oncogene mutations and inflammatory response, as well as increased 
induced micronuclei formations and nuclear protrusions (Shvedova et al., 2014). There is also 
evidence for ENMs developing ROS that may contribute to EMT (Tsuda & Gehr, 2014). 
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3. METHODS AND PROCEDURES  
3.1 Pristine Nanoparticle Preparation 
 The pNPs used in this study were iron (III) oxide (Fe2O3) and titanium oxide (TiO2) 
(Sigma-Aldrich, Missouri, USA). Approximately 10 mg of pNP powders were placed into 15 mL 
Falcon conical tubes in a disinfected fume hood using Georgia State University (GSU) approved 
safety measures and protocols. A 1 mg/mL suspension was prepared using a 1:1 ratio of powder 
to deionized H2O (di H2O) and vortexed until all the particles dispersed. One mL of each of these 
suspensions were transferred to new conical tubes and were sonicated using 75% amplitude for 4 
minutes to minimize agglomerates (ThermoFisher /Branson Ultrasonics Sonifier S-250D), 
Massachusetts, USA). These particle suspensions were then diluted to 5, 10, 15, and 20 µg/mL 
concentrations using either Small Airway Basil Media (SABM, Lonza, Maryland, USA) 
supplemented with 3% heat inactivated fetal bovine serum (FBS) if exposing SAEC or 
Dulbecco's Modified Eagle's medium (DMEM, Corning Inc., New York, USA) supplemented 
with 3% FBS and 1% penicillin/streptomycin (P/S) if exposing 16HBE. Only 3% FBS was used 
in each exposure media to ensure minimal agglomerate formation. Each suspension was vortexed 
for 30 seconds before use to ensure complete mixing.  
 
3.2 Released Nanoparticle Collection 
3.2.1 Selection of Nano-enabled Products  
 The released aerosols were collected from four liquid NEPs known to contain each of the 
pNPs tested in this experiment in their chemical formulation in varying concentrations. These 
products were also chosen because of their novelty and abundance in the consumer market as 
cosmetics. Products for both lighter skin tones and darker skin tones were chosen to assess the 
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potentially differing levels of toxicity from exposure for Caucasian versus African American 
women. In addition, costly products that are thought to be of higher quality versus more 
affordable, lesser quality ones were both selected to try to establish an association between SES 
and levels of exposure. A basic summary of all ENMs evaluated can be observed below in Table 
1. 
3.2.2 Released Nanoparticle Exposure System  
To collect released aerosolized particles from the NEPs in a controlled setting, an Aerosol 
Generation System was used, which consists of a glove box chamber, real time aerosol 
characterization instruments, and animal exposure chambers that are all controlled by fully 
automated custom software created and built by IEStechno (IES, Inc, West Virginia, USA). The 
instruments attached to the exposure system to measure real-time monitoring included a 
miniRAE 3000 (Honeywell, RAE systems) to measure VOCs, an air compressor (California Air 
Tools, San Diego, CA, USA), an air sampler with charcoal filter, DataRAM pDR-1500 Aerosol 
Monitor (ThermoFisher, Massachusetts, USA) to accurately measure active aerosol 
concentration, and laptop with software. An image of the Aerosol Generation System setup can 
be observed in Figure 1. To measure particle size and concentration, the TSI 3910 Nanoscan 
Nanoparticle Sizer (TSI, Inc., Minnesota, USA) was used to detect and size airborne particles 
between 10 – 1000 nm. A mannequin head was placed on rods inside of the chamber 10-12 
inches away from the airbrush wand (per manufacturer instructions for consumer application of 
products) with a “breathing” hole put near the nose to simulate inhalation. The air compressor 
was set at 30 PSI and the computer software regulated a constant flow rate of air inside the 
chamber at 11 L/min.  A steel enforced hose connected to the exposure chamber was attached to 
a vacuum output in a biosafety cabinet to create a closed system. Prior to collection, a test run 
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was conducted to ensure all connections were secure to each instrument and that the instruments 
and software displayed the correct settings and agreeable readings, as observed in Table 2.  
Particles were collected on mixed cellulose ester (MCE, pore size =0.8 µm, diameter = 37 
mm, SKC Inc., Pennsylvania, USA) membrane filter and support pad that were discharged of 
static and weighed before being placed in a cassette. The cassettes were sealed with electrical 
tape and attached to a hose on the outside of the exposure chamber. 8-10 drops of product were 
placed in the reservoir on top of the airbrush wand, as per manufacturer instructions for 
consumer use. The exposure was conducted for 20 minutes for each product and each filter was 
visibly checked for particles. Once each exposure was completed, the filter was removed and 
sealed while the entire chamber was thoroughly cleaned with 70% ethanol (EtOH) and allowed 
to dry to allow VOCs created from EtOH to dissipate. The filters were weighed after collection 
after discharging static which counted as a pre-extraction weight. The airbrush wand was 
removed, disassembled, and cleaned by pouring 70% EtOH in the reservoir and spraying it until 
no cosmetic residue was observed. This action was repeated with cleaning solution and di H2O to 
ensure no contamination occurred when switching exposures between products. The particles 
collected on the filter were removed into an aqueous sonication solution by placing 5 mL of di 
H2O into a sterilized plastic beaker and sonicated at 75% amplitude for 2 minutes. This solution 
represented a stock NEP solution that would be serially diluted into various concentrations of 
media upon exposure as described in the “Cell Exposure” section below. The filters were left to 
dry for 24 hours in a sterile fume hood and reweighed after discharging static to obtain the post-
exposure weight. The pre-exposure weight was subtracted from the post-exposure weight to 
obtain the concentration of particles in milligrams (mg) and were converted to micrograms (µg) 
(Table 4).  
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3.3 Colloidal Characterization 
 Since the rNPs contain several different compounds that may exhibit various physico- 
chemical and toxicological properties, it is important to characterize them to determine structure 
activity relationships. To determine the colloidal characteristics of dispersed rNPs and pNPs, 
particle size distribution was conducted using dynamic light scattering (DLS). DLS was 
conducted using a laser to scatter photons throughout a suspension of complete media and NPs 
and detects the magnitude and direction the photons bounce off from each molecule in the 
sample (Cohen, DeLoid, Pyrgiotakis, & Demokritou, 2013). This method can calculate 
parameters such as volume, count rate, settling velocity, presence of agglomerates via intensity 
of particle sizes (size distributions), hydrodynamic diameter (average size of agglomerates in 
nanometers), and zeta potential (electrostatic charges) to determine particle interaction and 
stability.  
 To analyze inorganic particulate constituents of the suspensions, the scanning electron 
microscopy with energy dispersive X-ray spectroscopy (SEM-EDS) method was used. SEM-
EDS provided data on morphological features of the NEPs, as well as an identification of metals 
(in percent) found in the formulation. These characterization assessments were performed at the 
Georgia Institute of Technology Institute of Electronics and Nanotechnology. To prepare the 
sample for SEM-EDS analysis, 1 mg/mL stock solutions for each released NEP was generated 
and 10 µL of each sample was placed on aluminum sample holder disks and dried for at least 24 
hours in a dehumidifying chamber. The samples were vacuum sealed prior to analysis to ensure 
removal of residual hydration.   
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3.4 Cell Culture 
 SAEC were cultured using 21 mL of complete Small Airway Growth Media (SAGM, 
Lonza, Maryland, USA), which was prepared by adding the contents of SAGM SingleQuots™ 
Kit (Lonza, Catalog No. CC-4124, Maryland, USA), which contained growth factors, such as 
Bovine Pituitary Extract (BPE), Hydrocortisone, Triiodothyronine, human Epidermal Growth 
Factor (hEGF), Retinoic Acid, Epinephrine, Transferrin, Insulin, Gentamicin/Amphotericin-B, 
and Bovine Serum Albumin – Fatty Acid Free (BSA-FAF) into SABM and homogenizing 
thoroughly. 16HBE were cultured using 21 mL of complete DMEM supplemented with 10% 
FBS and 1% P/S. Both cell types were maintained in T-75 flasks in an incubator set at 37°C in a 
5% CO2 atmosphere. The media were changed every other day, or as it was necessary, and cells 
were monitored under a light microscope to visualize day-to-day morphology and confluency.  
 
3.5 Cell Exposure to Pristine Nanoparticles and Released Nanoparticles  
 SAEC were subcultured from T-75 flasks into 96-well black plates (Corning Inc., New 
York, USA) before reaching a 100% complete cell monolayer using a saline buffer (Phosphate-
buffered saline (PBS) or (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES), 
ThermoFisher, Massachusetts, USA), gentle cell dissociation reagent (GCDR, ThermoFisher, 
Massachusetts, USA), and trypsin neutralizing solution (TNS, Lonza, Maryland, USA). This was 
conducted by aspirating the existing media in the flask, adding 4 mL of HEPES to the flask, 
recapping and gently swirling, removing the HEPES, then placing 4 mL of GCDR into the flask. 
The cells were viewed under the light microscope every 2-3 minutes and gently agitated to help 
release the cells from the bottom of the flask into the suspension. After the cells were in 
suspension (taking about 10-15 minutes, depending on the age of the passage), 4 mL of TNS was 
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incorporated into the flask and the cell surface area was washed gently multiple times with the 
solution. A total of 8 mL of cell suspension was pipetted into a clean 15 mL conical tube and 
spun in a centrifuge at 250xg for 10 minutes. After centrifugation, the supernatant from the 
conical tube was discarded and the cell pellet was resuspended in 1 mL of SAGM. Cell number 
and viability was visualized using a hemocytometer with 10 µL of cell suspension mixed with 10 
µL of 0.4% Trypan Blue Solution (ThermoFisher, Massachusetts, USA). Dilution of the cell 
suspension into SAGM was calculated using a guideline of a cell density of 2,200 cells/well. The 
96-well plates were seeded using 100 µL of the diluted cell suspension. The media was replaced 
after 24 hours and cells were used for exposure after 2-3 days, or when 80-90% confluency was 
reached.  
 16HBE cells were subcultured in a similar fashion, apart from using a 1:4 ratio of 
complete DMEM media and recovered cells. Trypsin (0.25%, Corning, New York, USA) was 
utilized instead of GCDR as they are a cell line and are less sensitive to damage from trypsin. In 
addition, 16HBE cells are smaller and tend to proliferate more rapidly than primary SAEC, thus 
trypsin ensured that all the cells were collected off the flask and into suspension. When placed 
into 96-well plates, the cells were confluent enough for exposure within 24-48 hours.   
 Once the cells on the 96-well plates reached optimal confluency, the media was aspirated, 
and cells were washed 3x with 200 µL PBS. After ENM suspensions and dilutions were prepared 
for that day as per “Pristine Nanoparticle Preparation” instructions above, 50 µL of SABM + 3% 
FBS (or DMEM exposure media for the 16HBE cells) were added to all wells, as well as 
exposed to 50 µL of the designated ENM suspensions with the various concentrations listed 
above. The positive and negative controls were not exposed to any ENM suspension and were 
instead given 100 µL of exposure media. The positive controls are listed in each assays’ sections 
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that follow. The cells were exposed for a period of 24 hours. After the exposures concluded, 
various assays were conducted to measure the endpoints for this research including quantitative 
and qualitative analysis of oxidative stress due to reactive oxygen species (ROS) created by rNPs 
and pNPs, cellular viability, and epithelial mesenchymal transition (EMT) via 
immunohistochemistry and western blot.  
 
3.6 Reactive Oxygen Species Generation 
 ENMs produce ROS that can have copious deleterious effects on normal, healthy cells. 
The CellRox® Oxidative Stress Orange Reagent (Invitrogen, California, USA), which localized 
in the cytoplasm, was utilized to detect and visualize interaction of ROS with live cells post-
exposure to ENMs. The positive control for this assay was made using a stock solution of 100 
µL hydrogen peroxide into 10 mL of PBS and adding 100 µL of this dilution to the positive 
control cells. The reagent was prepared by combining 10 µL of CellRox® Orange to 5 mL of 
PBS to create a 5 µM concentration and covered in tin foil until use.  
This assay was conducted by removing the ENM particle suspension from the cells and 
cells were washed 2x with 200 µL of PBS. Fifty µL of the prepared reagent was added to the 
cells and incubated in the dark at 37°C for 30 minutes. After incubation, the reagent was 
removed, and cells were washed 3x with 200 µL of PBS. To fix cells, 50 µL 3% 
paraformaldehyde (Invitrogen, California, USA) was added for 15 minutes, removed, and cells 
were washed 2x with 200 µL of PBS before adding 100 µL of PBS to keep cells in solution. The 
relative fluorescence intensities were analyzed and imaged using a fluorescent microscope 
(EVOS FL Auto 2, ThermoFisher, Massachusetts, USA) using excitation/emission maxima of ~ 
545/565 nm. 
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3.7 Total Glutathione Assessments 
 Glutathione (GSH) is an antioxidant normally found in eukaryotic cells. GSH is a three-
amino acid polypeptide used as an indicator for oxidative stress. The GSH-Glo™ assay 
(Promega, Wisconsin, USA) was a luminescent assay used that measured total glutathione levels 
in cells and served as a quantitative validation for the CellRox® assay in this study. The positive 
control for this assay was made using a stock solution of 100 µL hydrogen peroxide into 10 mL 
of PBS and adding 100 µL of this dilution to the positive control cells. This assay works by 
transforming Luciferin-NT, catalyzed by the enzyme Glutathione S-Transferase, into Luciferin 
when GSH is present, producing a detectable light emission.  
When the GSH-Glo™ Reagent 1X was prepared, 10 µL of Luciferin-NT and Glutathione S-
Transferase were each added to every 1 mL of GSH-Glo™ Reaction Buffer that was needed and 
the reagent was deposited into a 15-mL conical tube and shielded from light.  When the 
Luciferin Detection Reagent was prepared, a bottle of reconstitution buffer with esterase was 
combined with the bottle of Luciferin Detection Reagent and mixed by inversion until fully 
dissolved. This assay was conducted by removing the ENM particle suspension from the cells 
and washing them 2x with 200 µL of PBS. Fifty µL of GSH-Glo™ Reagent 1X was added to the 
wells, shaken briefly, then incubated at room temperature for 30 minutes. After incubation was 
complete, 50 µL of Luciferin Detection Reagent was added to the wells, shaken briefly, and 
incubated at room temperature for 15 minutes. Luminescence was then measured in a microplate 
reader (EnSpire by PerkinElmer/Cytation5 by BioTek). 
 
3.8 Cellular Viability Evaluations  
 Cellular viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
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diphenyltetrazolium bromide (MTS) colorimetric assay (CellTiter 96 Aqueous One Solution, 
Promega, Wisconsin, USA). The MTS assay measured the cells’ metabolic activity by 
introducing tetrazolium salt to determine the metabolic capacity of cells after exposure to rNPs 
and pNPs. Prior to conducting the MTS assay, 10 µL of 10X lysis solution (Promega, Wisconsin, 
USA) was added to positive control wells for 10-15 minutes. The MTS reagent was prepared 
making a 1:10 dilution of the reagent into SABM/DMEM, vortexed thoroughly, and shielded 
from light. This assay was conducted by first removing the particle suspension and washing cells 
2x with 200 µL PBS. Next, 100 µL of the prepared MTS reagent was administered to each well 
and incubated at 37°C for 1 hour, while examining periodically for color change. After 
incubation, the absorbance of each well/plate was analyzed by a fluorescent microplate reader 
(EnSpire by PerkinElmer/Cytation5 by BioTek) at 490nm. 
 
3.9 Epithelial-mesenchymal transition  
 EMT is a biological process that occurs when epithelial cells lose their adhesive 
properties during inflammation and transform into fibroblasts (Kalluri & Neilson, 2003). Once 
these epithelial cells display fibroblast or myofibroblast phenotype, they can translocate to the 
extracellular matrix, where they accumulate, and fibrosis can begin to occur (Guarino, Tosoni, & 
Nebuloni, 2009). This study looked at 2 proteins related to EMT: E-cadherin and vimentin. The 
immunocytochemistry (ICC) assay (R&D Systems, Minnesota, USA) contained 2 fluorescent 
antibodies to stain (pseudo-white and green fluorescent protein (GFP)) and visualize protein 
levels differences of E-cadherin and vimentin, respectively. A 4',6-diamidino-2-phenylindole 
(DAPI, Thermofisher, Massachusetts, USA) stain was utilized to visualize cell nuclei. 
Transforming growth factor beta (TGFβ, R & D Systems, Minnesota, USA) served as the 
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positive control for this assay as it has been known to trigger EMT and 1.5 µL of 2 µg/mL stock 
was added 24 hours before the assay was conducted (Guarino et al., 2009).   
 This assay was conducted by removing the ENM particle suspension from the cells and 
washing them 2x with 200 µL of PBS. Cells were fixed by adding 50 µL of 3% 
paraformaldehyde (Invitrogen, California, USA) for 15 minutes then washed off 1x with 200 µL 
of PBS. To block, 100 µL of 3% Bovine Serum Albumin (BSA) blocking agent (Invitrogen, 
California, USA) was added to the cells and incubated at 37°C for 1 hour. After incubation, 35 
µL of both stains were pipetted into 245 µL of 3% BSA solution and 45 µL of this stain solution 
was added to wells and incubated from 1.5-3 hours at 37°C. After completion of the previous 
step, cells were washed 2x with 200 µL of PBS and 100 µL of PBS was added along with one 
drop of DAPI for 20 minutes then imaged using a fluorescent microscope (EVOS FL Auto 2, 
ThermoFisher, Massachusetts, USA). 
 
3.10 Protein Expression 
  To determine if there were detectable differences in EMT-related protein levels between 
treatments and exposure time frames, western blots were conducted. To extract the protein 
lysates, 6 well plates were seeded at a cell density of 3,000 cells/well and grew until 80-90% 
confluency. Once confluent, dilutions of the rNPs and pNPs were conducted and the cells were 
exposed for either 24 hours, 7 days, or 21 days. Protein extraction was conducted by removing 
the spent exposure and adding 10 µL Halt™ Protease Inhibitor Cocktail 100X (ThermoFisher, 
Massachusetts, USA) to every 1 mL Mammalian Protein Extraction Reagent (M-PER™, 
ThermoFisher, Massachusetts, USA). This solution was applied to the cells and the wells were 
scraped using a cell scraper to remove all the cells adherent to the plate. These protein lysates 
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were collected into microcentrifuge tubes and spun at max speed (13,000 x g) for 10 minutes. 
The supernatant was collected into sterile microcentrifuge tubes and frozen in -80 °C until use 
for western blot.  
 Prior to conducting western blots, a Bradford protein assay (Thermofisher, 
Massachusetts, USA) was conducted to determine the protein concentration found in each lysate. 
The protein concentration determined what percent polyacrylamide gel was best to use and how 
much lysate to load in each well of the gel. 10 µL of a protein marker was used on each gel and 
gels were run at 80 V for 2 hours. When transferring the proteins to blotting paper, once the 
cassettes were assembled with a tight seal, they were covered in ice and the transfer was run at 
0.35 A for 2 hours. After the transfer was complete, the blots were submerged in Ponceau S stain 
(Sigma Aldrich, Missouri, USA) for a few minutes, then rinsed with mixture of tris-buffered 
saline (TBS) and Tween 20 (TBST) until coloration disappeared. The blots were blocked 20-30 
minutes in a 10% skim milk solution with primary antibodies (either E-cadherin, vimentin, and 
beta-actin or Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the positive control), 
rinsed, and stored overnight at 4°C. The next day, 10 µL of secondary antibodies (either mouse 
or rabbit) were added to 10 mL BSA. The blots were washed 3 times for 5 minutes each with 1X 
TBST on a shaker. The gels were cut based on protein size and were covered in the secondary 
antibody solution for two hours and then developed on films or visualized electronically 
(Amersham™ Imager 680, GE Healthcare Life Sciences, Pennsylvania, USA).  
 ImageJ (NIH, Maryland, USA) was used to analyze protein intensities and changes in 
expression quantitatively. This was conducted by converting each image into greyscale (8-bit) 
and outlining each lane to obtain a profile plot for each band. The profile plots displayed peaks 
of intensity found within each band, along with any background noise the western blot may have 
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generated. Each peak was closed off and each area obtained was converted to percent value of 
the standard (negative control for each gel). Relative density was calculated by dividing the 
percent value for each sample by the percent value for the negative control. To correct for any 
possible unequal protein loading errors during western blots, adjusted densities were calculated 
by dividing the relative density from each sample from either E-cadherin or vimentin by the 
relative density of the same sample from Beta-actin (loading-control). This procedure was 
conducted for each gel and protein analyzed. 
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4. RESULTS 
4.1 Selection of Nano-enabled Products  
 Cosmetics are one of the more widely used products that are known to contain ENMs, as 
well as metal NPs (Contado, 2015). The guiding framework that was used to select the specific 
NEPs included in this study was based on a panel of emerging products that are increasing in 
popularity amongst various consumers and products that contained a high amount of metal NPs. 
The following selection criteria were also used: (1) Two brands of cosmetics with different price 
points were chosen to address a possible differing level of exposure risk between higher and 
lower levels SES; (2) Light and dark shades of each brand were chosen to address any potential 
differences in toxicity and chemical makeup that could influence health disparities and outcomes 
for different races. 
 
4.2 Detection of Metal Nanoparticles in Selected Nano-Enabled Products 
To determine the metal composition and indirectly determine the amount of metal NPs of 
each selected NEP, we employed inductively coupled plasma mass spectrometry (ICP-MS). In 
Figure 2, the metal composition of each selected NEP was labeled and displayed in parts-per-
million (ppm) or parts-per-billion (ppb). “Cosmetic Line 1” represents the expensive brand and 
“Cosmetic Line 2” was the inexpensive brand. Both AA4 and S4 were composed of aluminum 
(Al), magnesium (Mg), iron (Fe), and titanium (Ti), with most of the abundance belonging to the 
latter two metals. Although both products were darker shades, AA4 had close to 30,000 ppm of 
Ti and about 5,000 ppm of Fe, while S4 had almost equivalent quantities of Fe and Ti (~30,000 
ppm). The other shades included in the figure have considerably less metal composition. S1 was 
the lightest shade available from Cosmetic Line 1 and Ti was still observed within its 
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composition (Figure 2). The lightest shade of Cosmetic Line 2 (AA8) was chosen to be 
comparable to S1. AA9 was not chosen as it was not a foundation and was meant to be applied as 
a shimmer over the initial layer of makeup. Given the prevalence of Fe2O3 and TiO2 within the 
products, they were selected as the most relevant pNPs of interest.  
 
4.3 Monitoring of Aerosolized Nano-enabled Products 
To monitor the concentration of released rNPs during normal consumer usage of about 20 
minutes, proprietary software provided by IES Tech was used. The Aerosol Generation System 
was set to regulate the total concentration level of 10 mg/m3 in the chamber and each exposure 
reached that threshold limit, as observed in Figure 3, before decreasing until a safe level (<1 
mg/m3) was reached. The average concentration over the total duration was recorded with the 
highest average concentrations observed in both darker shades and the lowest average 
concentration observed in AA8. AA4 also had the most gradual and consistent increase in 
concentration, as compared to the other rNPs (Figure 3).  
4.3.1 Aerodynamic diameter of Nano-enabled Products 
 In addition to recording the concentrations over the duration of exposure, we employed 
scanning mobility particle sizer analysis (SMPS) for S4 to assess the aerodynamic diameter 
during consumer usage. In Figure 4, the SMPS data for S4 was observed during the same 
exposure as S4 in Figure 3. In Figure 4, the mean particle diameter size aerosolized from S4 
ranged from 0 to ~180 nm, with both particle concentration (>6,000 particles/cm3) and average 
particles count (~500) peaking at ~125 nm.  The highest particle concentration was observed at 
or below this threshold, which indicates that, when aerosolized, S4 produces many small 
particles that agglomerate in elevated concentrations. Subsequently, we observed the smallest 
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particle concentration and average particle count with the largest particles (~180 nm), indicating 
there were less of these larger particles present during exposure to S4. There was a large 
decrease observed as the exposure finished and the concentration of particles decreased to a safe 
level. The data indicated that there was a substantial amount of ultrafine (nano) particles present 
in S4 in high concentrations, which warranted the need for toxicological investigation for 
inhalation exposure.  
 
4.4 Offline Physico-chemical Characterization of Released Nanoparticles 
4.4.1 Scanning Electron Microscopy with Energy Dispersive Spectroscopy  
 To understand the physical topography and elemental composition of the sampled/ 
collected rNPs, Scanning Electron Microscopy with Energy Dispersive Spectroscopy (SEM-
EDS) was utilized and the results can be observed in Figure 5 and Table 3. Figure 4 displays the 
morphology of each rNP observed using SEM that was taken from a 1 mg/mL sonicated stock 
suspension of each rNP. There were observed agglomerations in all images but AA4 had the 
most complex looking structure, as it was observed to be layered with a more uneven textured 
appearance than the three other rNPs. AA8 was observed to have the smallest particle sizes and 
numerous agglomerates of differing sizes scattered around the field of view. S1 and S4 appeared 
nearly identical, save the additional agglomeration and particles found in S4. Visualizing the 
sizes of these particles may provide evidence that can be complimentary with the toxicological 
assessment results to understand how agglomeration and particle size may affect the 
toxicological outcomes of cells. 
 In Table 3, a comprehensive elemental assessment was provided for each of the rNPs to 
provide more information of chemical formulation differences between the shades and brands. 
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Each rNP had a differing number of elements, as each of the detected “spectra” labeled on Figure 
4 emitted X-rays for specific elements contained within their agglomerates as “peaks” based on 
the abundance of each element. Information displayed on the table included sample name, the 
elements examined in each product, line type (electron shell that was filled by an electron when 
vacant), apparent concentration, k ratio, percent weight of each element (Wt%), percent weight σ 
(error, Wt% Sigma), and standard label. The two pNPs tested in this study were bolded with red 
text for each sample and all percent weights were sorted in descending order. Three out of the 
four rNPs had titanium (Ti) within their composition with the largest percent weight in AA8 at 
52.19%, followed by S1 with 38.79%. This outcome was expected as AA8 and S1 were the 
lighter shades of product and Ti powder is white and commonly used to lighten the pigments in 
various NEPs. However, AA8 was the only rNP that does not have aluminum (Al) or oxygen (O) 
within its composition but instead had bromine as its only other element reported (47.81%), 
which might contribute to the smaller particle size observed in Figure 5.  Iron (Fe) made up over 
65% of AA4’s composition, which would explain why it was such a dark shade and could have 
impacts on toxicity. S4 was the only product that had both Ti and Fe within its composition, 
which together made up over 50% of its overall composition. S4 also had a total of 4 reported 
elements as its composition, which was the most out of all rNPs tested. Since S4 was darker and 
part of the more expensive cosmetic line, it could explain the slightly more complex elemental 
composition compared to AA4 and AA8.   
 
4.5 Extraction of Sampled Aerosolized Nano-enabled Products from Collection Media 
4.5.1 Filter Weights and Calculations 
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Aerosolized NEPs were sampled and the resulting rNPs were collected onto mixed 
cellulose ester filters (MCE). The rNPs were then extracted using aqueous sonication method 
(see extraction protocol in Methods and Protocols section). In Table 4, the pre- and post-
extraction filter weights were measured on a balance and milligrams (mg) of mass collected were 
calculated by subtracting those values. To convert from mg to micrograms (µg), the mass 
collected was multiplied by 1,000 and divided by the amount of deionized water (di H2O) used to 
sonicate the particles off the filter into a stock suspension (5 mL). This provided the percent of 
total mass collected off filter. The darker shades (AA4 and S4) accumulated the greatest amounts 
of particles on the filter during real time exposure.  
 
4.6 Colloidal Characterization 
4.6.1 Colloidal Properties of Raw Products, Released Nanoparticles, and Pristine Nanoparticles 
 The colloidal properties of the raw or whole product, rNP and pNPs were tested to 
determine how factors such as size distribution and zeta potential might affect toxicity and 
cellular responses. In Table 5, dynamic light scattering (DLS) values for raw products, rNPs, and 
pNPs colloidal properties were listed, with pNPs serving as the reference controls. These values 
were conducted in triplicate with means and standard deviations reported on the table. Values 
that were unable to be collected were listed as “N/A”. Only raw product data was collected for 
the darker shaded cosmetics, as those were hypothesized to be the most toxic. Each sample was 
diluted in either di H2O or exposure media used for SAEC and 16HBE (SABM and DMEM, 
respectively) that contained 3% FBS. Column 3 displays the hydrodynamic diameter with S1 and 
S4 (in both raw and released) had a more noticeably larger hydrodynamic diameter in all types of 
media, compared to the other raw and released products. The raw products had the largest 
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diameters in SABM, while, except for Fe2O3, all other samples had the smallest diameter when 
diluted in the same media. Out of all the rNPs, AA4, AA8, and S1 had the largest hydrodynamic 
diameter when dispersed in di H2O, while S4 had a slightly larger hydrodynamic diameter in 
DMEM. Light shades AA8 and S1 varied considerably in size, as AA8 had the smallest 
hydrodynamic diameters in every media compared to all the samples and S1 had the largest for 
rNPs, especially in di H2O. Fe2O3 had almost doubled in size when comparing dispersion in di 
H2O to SABM. The opposite trend was apparent in TiO2. 
 Polydispersity Index (PdI) was used to determine the uniformity of the colloidal 
suspensions. According to column 4 on Table 5, TiO2 had the lowest PdI out of all samples in 
both exposure media, therefore had the most uniformity. AA8 was the only rNP that had the 
most similar uniformity as the raw products, followed by AA4. Both S1 and S4 had much higher 
PdI values in all types of dispersion media, suggesting that there could be particles of contrasting 
sizes present, which could affect exposure and toxicity outcomes.  
 The zeta potential of samples determined how positive or negative the pNPs and rNPs 
were, thus influencing their surface chemistry. The most notable zeta potential values on Table 5 
belonged to both darker shades of cosmetics AA4 and S4 and were extremely negative in both 
exposure media compared to the other samples. The only positive values for zeta potential were 
for the raw product AA4 dispersed in di H2O, S4 in SABM, and pNP Fe2O3 in di H2O. Pristine 
Fe2O3 was also observed as moderately negative when dispersed in SABM but still less negative 
than AA4 and S4. 
 Conductance measured the amount of current that was permitted to pass through the 
substance. In Table 5, both the darker shades AA4 and S4 were highly conductive in both the 
cell media but had little-to-no conductivity in di H2O. Fe2O3 also had a high conductivity when 
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dispersed in SABM and was only slightly higher than AA4 and S4. All samples have a 
conductance value of <2.2 when dispersed in di H2O. 
 
4.7 Comparative Toxicological Assessments of Pristine and Released Nanoparticles 
4.7.1 Rationale 
 SAEC and 16HBE cells were chosen for this study because they each represent an 
important cell type found in the lungs that were potential targets of NEP exposures during 
consumer usage. 16HBE are smaller and reside in the upper airways while SAEC are larger and 
reside in the distal regions of the lung. Since ultrafine particles tend to agglomerate and penetrate 
deeper into the lungs, it was expected that SAEC might experience greater effects when exposed. 
Since human bronchial cells are exposed at a higher frequency to xenobiotic insults, they may be 
inherently more tolerant and resilient to airborne insults in comparison to SAEC. Furthermore, 
we chose to compare human, primary SAEC and an immortalized cell line 16HBE to understand 
the difference in sensitivity, susceptibility, and toxicity on using these two types of cells with 
acute exposure to pNPs and rNPs. Thus, these cell types were chosen to mimic and model 
inhalation exposures of NEPs. There is an increasing trend in the cosmetic industry to aerosolize 
products that have never been tested before with regard to pulmonary exposures. A product may 
be deemed “safe” but, unless studied intensely and tested thoroughly before release into the 
market, it may become more toxic when introduced to other exposure routes. Importantly, the 
assessed NEPs or cosmetics were determined “safe” for dermal exposure and application only 
using irritation and sensitization assessments. Companies that are choosing to use ENMs in their 
products may be seeking better visibility using these materials as a marketing strategy, which 
may overshadow safety considerations. The hypotheses that were analyzed during this study 
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were as follows: (1) The rNPs may be more toxic than pNPs due to enhanced toxicological 
effects mediated by their complex composition. (2) The darker shades of cosmetics (AA4 and 
S4) may exhibit the most toxic effects because of higher levels of constituent metal NP, thereby 
posing more risk for medium and darker skinned individuals. (3) The inexpensive brand of 
cosmetics (AA, cosmetic line 2 in Figure 2) may exert more toxic effects and pose more risk for 
individuals with lower SES because of detected contaminants such as arsenic and lead that may 
be the result of manufacturing or the use of poorer quality materials. 
4.7.2 Reactive Oxygen Species Generation Assessment 
 ROS generation and resulting oxidative stress can affect cellular functioning, signaling, 
and viability that may eventually lead to inflammation, cardiovascular disease, and other adverse 
health outcomes. First, preliminary data was gathered to assess if raw product AA4 would 
produce ROS. Figure 6 demonstrated a serial dilution of AA4 in SABM with SAEC with an 
addition of DAPI stain to visualize the nuclei. Through this serial dilution, it was observed that 
the oxidative stress peaked at 1-400 dilution (Panel C) and decreased with increased dilutions 
(Panels D and E). This image confirmed that there was ROS generated after 24-hour exposure to 
AA4. This information helped detect the dose-response relationship for AA4 and SAEC, which 
can be applied to other products. 
Figures 7-12 presented detection of ROS using a fluorescent permeating dye that had an 
excitation/emission maxima of ~ 545/565 nm. Fe2O3, TiO2 and the rNPs were exposed for 24 
hours according to the “Cell Exposure” section of Methods and Protocols above using 5, 10, 15, 
and 20 µg concentrations. These concentrations were compared to a negative control consisting 
of cells being only exposed to exposure media during the 24-hour period.  SAEC had increased 
ROS levels occur with every treatment compared to 16HBE, indicating that SAEC were more 
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sensitive to generation of ROS upon exposure even only after 24 hours. Comparing the pNPs 
(Figures 7 and 8), TiO2 produced significant amounts ROS with the 10 µg dose and became less 
noticeable at 15 µg. Fe2O3 induced a small but visible increase in ROS as concentration 
increases, which was also observed in 16HBE. Regarding the rNPs (Figures 9-12), ROS were 
generated by each treatment in SAEC. AA4, like Fe2O3, elicited higher levels of ROS due to the 
10 µg dose and less at 15 µg. AA8 had an ample but consistent amount of ROS production at all 
doses, like the other light shade S1. S4 exposure induced increased ROS in both 10 and 15 µg 
doses for SAEC. For 16HBE, the only prominent increases in ROS were for AA4 and S4 
exposures at 15 µg.  
4.7.3 Total Glutathione - GSH 
 To determine oxidative stress quantitatively, the total GSH assay was conducted with an 
additional dose of 20 µg (Figures 13 and 14). Data was normalized and analyzed for significance 
using ordinary one-way ANOVA testing followed by Dunnett’s test with alpha = 0.05. SAEC 
GSH were affected with each treatment and several values were deemed to be significant. For the 
highest dose of Fe2O3 (Figure 13, panel A), total GSH production was reduced by 50% compared 
to the negative control (p <0.0001). TiO2 displayed a steady decline in panel B with the highest 
dose having slightly increased luminescence than 20 µg Fe2O3. On Figure 14, AA4 (panel A) and 
S1 (panel C) induced more than a 50% decrease in luminescence for SAEC but AA4 was found 
to be significant in 3 out of the 4 doses administered, with the lowest dose (5 µg) mean being 
71.6874. S4 exposures (panel D) caused a significant decrease in GSH for 3 of the 4 doses but 
lesser than AA4. The lighter shades AA8 (panel B) and S1 (panel C) appeared to display similar 
shapes in their graphs, with 20 µg S1 being the exception, which indicates that there was less 
oxidative stress compared to the darker shades of rNPs. In comparison to SAEC, 16HBE was not 
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significantly affected by any doses or treatments and, in fact, continued to proliferate more than 
the negative control in most cases. The only significant values were determined in Figure 14 at 
the 5 µg dose for S1 and S4 (panels G and H, respectively) for increased proliferation compared 
to the negative control (p = 0.0182 and p=0.0357, respectively).  
4.7.4 Cellular Viability – MTS 
 To determine the effects of pNPs and rNPs exposures on cellular viability, the MTS assay 
was conducted for 5, 10, 15 and 20 µg doses (Figures 15 and 16).  Data was calculated as 
described above in the “Total Glutathione - GSH” section. The viability of SAEC was affected 
by all treatments significantly with at least one dose. Both pNPs displayed a decreasing linear 
trend with 15 and 20 µg doses of TiO2 having p <0.0001 (Figure 15, panel B). For the rNPs 
(Figure 15), AA4 had the most uniform decreasing linear trend with the highest concentration 
reducing SAEC viability by about 40% (panel A). S4 significantly reduced viability with each 
dose but, apart from the 15 µg dose, the mean of each hovered around 75-77%, or a 23-25% 
reduction in cell viability (panel D). S1 had a reduction in viability except for 20 µg, which 
increased possibly due to human error (panel C). AA8 was the only released treatment that had 
only one significant value, which was 20 µg, and had a less linear shape and more cosine-like, 
with wider standard deviations compared to the other treatments (panel B). 16HBE did not have 
any significant decrease in cellular viability as compared to SAEC but the largest decrease was 
observed for 20 µg S1 and S4 by about 15% (Figure 16, panels G and H). 
4.7.5 Epithelial Mesenchymal Transition - Immunocytochemistry 
 After determining that SAEC were more sensitive to exposure to ENMs acutely at the 
previously described concentrations, the immunocytochemistry (ICC) fluorochrome assay was 
conducted to see if any phenotypic changes occurred after exposure to 5, 10, and 20 µg 
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concentrations of either pristine Fe2O3 or released AA4. Due to financial and time constraints, 
AA4 was the only rNP that the ICC assay was conducted on and was chosen based on its 
heightened toxicity compared to the other rNPs. The results of 24-hour exposure can be observed 
in Figure 17. For this assay, the proteins E-cadherin and vimentin were visualized, using pseudo-
white and green fluorophores, respectively. The nuclei were also stained blue with DAPI in the 
AA4 treatment. According to the EMT pathway, a decrease in E-cadherin expression can lead to 
increased vimentin expression. Since E-cadherin is involved with adherence, this decrease can be 
associated with morphologic change. In the negative control, all the proteins were readily 
observed but, with the 5 µg Fe2O3 concentration, a decrease in E-cadherin was observed with 
primarily vimentin. At the 10 µg concentration, vimentin was observed to be less prominent and 
at 20 µg, vimentin was the only protein visualized. For the AA4 exposures, it was difficult to 
visualize the stains based on poor washing or human error in techniques, however the cells were 
not as tightly formed together as they were with Fe2O3, suggesting loss of tight cell junctions and 
viability. In Figure 18, the ICC assay was conducted after a 7 day-long exposure to Fe2O3. The 
results were more dramatic as compared to the 24-hour exposure. Compared to the negative 
control and 24-hour treatments (Figure 17), all 3 doses of Fe2O3 produced notably increased 
vimentin and were observed as decreasing incrementally with increasing doses. This could be 
due to an increased loss of E-cadherin expression, therefore a less “white” or bright image. The 
cell morphology was also altered from a spherical shape to an elongated shape indicating EMT 
commonly found in airway epithelium undergoing fibrotic changes. 
4.7.6 Western Blot 
Although EMT was found in ICC assessments, western blot analysis of SAEC protein 
aliquots obtained after 3-week exposures were not as conclusive. Three-week exposures were 
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conducted to observe how sub-chronic exposures might affect the SAEC EMT protein levels but, 
as they are sensitive, reduced concentrations of 2 µg and 5 µg were used to ensure adequate 
protein collection. The western blot data was conducted in Figure 19 for pNPs (Fe2O3 and TiO2 
abbreviated as “Fe” and “Ti”, respectively) and rNPs. Beta-actin was used as a loading control, 
which was observed in all samples but did not display uniform intensities. This could have been 
attributed to uneven transfer. In both gels, there was little visual difference in E-cadherin 
intensities between the negative controls and positive controls (TGFβ), save NC2 on gel 1. 
Regarding the pNPs and rNPs, E-cadherin intensities in gel 1 were relatively similar but the 
vimentin intensity for 2 µg AA4 was highest, which could indicate there was increase in 
vimentin. In gel 2, higher intensities of E-cadherin were observed in the higher (5 µg) doses of 
AA8, S1, and S4 and there were little visible bands for vimentin for the same gel. To provide a 
more comprehensive comparison of band intensities, graphs were created using the relative 
intensities adjusted for a negative control on each gel (Figure 19). This was conducted in ImageJ 
by calculating percent peak area and relative density by dividing by the area of the negative 
controls then adjusting to include differences in beta-actin for each treatment (see Methods and 
Protocols section labeled “Protein Expression” for further details). Comparing the treatments in 
the graph to the negative controls, there was a decrease in E-cadherin only for the positive 
control on gel 1 but a decrease for all treatments on gel 2. For vimentin, there was an increase in 
all treatments on gel 1 compared to the negative control and a slight elevation in 2 µg AA8 and 5 
µg S4. When comparing treatments across both proteins, one positive control on gel 1 displayed 
a decrease in E-cadherin and increase in vimentin. On gel 2, all treatments had a decrease in E-
cadherin and an increase in vimentin, except for 5 µg AA4 and the positive control on gel 2, 
which increased but to a lesser extent than the negative control. This suggested that EMT might 
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have occurred with most of the rNPs and these western blot results warrant subsequent trials to 
obtain more reliable data for sub-chronic exposure effects on EMT.   
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5. DISCUSSION AND CONCLUSION 
Innovation in nanotechnology has led to rapid and increased development of NEPs that 
has warranted the need for safety investigations due to the incorporation of metal ENMs. 
Previous studies have shown that exposure to ENMs elicit toxic effects through complex 
mechanisms, which can lead to adverse health outcomes, such as fibrosis and reduced pulmonary 
function (Gatoo et al., 2014; Maynard et al., 2006; Meng et al., 2007; Nel, Xia, Mädler, & Li, 
2006; N. Singh et al., 2009). Yet, over 70% of NEPs do not have enough information to support 
the claim that ENMs are used, which indicates lack of safety or ethical considerations (Vance et 
al., 2015). This lack of knowledge has piqued interest in the scientific community as the 
applications and uses for ENMs have increased to encompass a variety of products, thereby 
widening the potentially exposed population (Ray, Yu, & Fu, 2009). Since ENMs are being 
developed continually and are used to make products more durable, it raises concerns for the 
possible adverse effects that might result from this enhancement. Specifically, in cosmetics, 
almost all major brands are utilizing nanotechnology in their products to make them longer-
lasting, penetrate skin deeper, and improve color and chemical reactivity (Raj, Jose, Sumod, & 
Sabitha, 2012). TiO2 is commonly used as a protectant from UV rays and iron oxides are used as 
pigments to produce various shades of cosmetics, such as red and orange (Borowska & Brzóska, 
2015). Specifically, Fe2O3 is one of the most universal and widely-used iron oxides in cosmetics 
(Wawrzynczak & Nowak, 2011). With these differences in various levels of metal-containing 
ENMs, such as Fe2O3, used to manufacture darker and lighter shades of NEPs, it may cause 
dissimilar effects in darker-skinned individuals versus lighter-skinned individuals. Since some of 
these NEPs now have a more widespread application technique via airbrush, inhalation exposure 
has become a more prominent exposure pathway as popularity of this use has increased. This has 
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led to the characterization of aerosolized nanoparticle releases from NEPs (Nazarenko et al., 
2011, 2012; Pal, Watson, et al., 2015; D. Singh et al., 2017). In an effort to build on this 
research, this study was conducted to examine the potential toxicological effects and differences 
regarding inhalation exposure to pNPs and rNPs and determine if there is any increased risk for 
susceptible populations.  
 This study compared the physico-chemical characteristics and toxicological profiles of 
pNPs and rNPs using SAEC and 16HBE cell types to determine ROS generation, cellular 
viability, EMT, and up- or downregulation of EMT proteins using western blots. The darker 
shades of NEPs AA4 and S4 had the highest Fe concentrations when examined through ICP-MS 
and EDS, compared to the lighter shades AA8 and S1 containing more Ti. This chemical 
compositional difference alone can affect how particles interact with their environment and 
influence toxicological endpoints, such as cellular viability (Gatoo et al., 2014; Maurer-Jones, 
Gunsolus, Murphy, & Haynes, 2013; Pal, Watson, et al., 2015). In addition, the zeta potential 
values for AA4 and S4 obtained when dispersed in either exposure media was approximately 
between 8 and 25-fold more negative than AA8 and S1. The changes in zeta potential can be 
affected by factors such as change in pH and this changed zeta potential can influence cellular 
viability, as supported by Berg et al. (2009). The negative zeta potential values are also reflected 
in the high conductance both darker shades of rNPs exhibited in exposure media. Fe2O3 was also 
found to have an extremely negative zeta potential in exposure media, which was in abundance 
in the darker shades and explain partially why there was a huge zeta potential difference between 
dark and light shades of NEPs. However, since the negative zeta potential was greater in rNPs, 
they may exhibit greater effects, such as influenced toxicity, based on their surface properties 
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compared to pNPs, as described in multiple studies (Berg et al., 2009; Lundqvist et al., 2008; 
Nan, Bai, Son, Lee, & Ghandehari, 2008; Xia et al., 2006). 
The differences in composition between the expensive and inexpensive cosmetic lines 
(cosmetic lines 1 and 2, respectively) are also apparent when the hydrodynamic diameter was 
observed, with cosmetic line 2 rNPs having a smaller diameter compared to cosmetic line 1 
rNPs. This was observed in the SEM images, save for AA4, which had a more textured, rough 
structure with large agglomerations present, which could be expected with the higher percentage 
of Fe present. The differing sizes in pNPs observed when dispersed in exposure media versus di 
H2O has been observed in other studies and has played a role in changes in toxicity (Colvin, 
2003; Hou, Westerhoff, & Posner, 2012; Jiang, Malavia, Suresh, & George, 2009; Sager et al., 
2007). When comparing uniformity of particle suspensions (PdI), cosmetic line 2 rNPs had the 
most uniformity while cosmetic line 1 rNPs had much lower uniformity compared to cosmetic 
line 2 rNPs and raw products. This could be indicative of the more complex chemical 
formulations found in the more expensive products. These complex physico-chemical properties, 
such as shape, aggregation, and surface area, has been thought to play a major part in toxicity 
and has been confirmed in a few studies to increase cytotoxicity with pNPs (Gatoo et al., 2014; 
Hu, Xie, Tong, & Wang, 2007; Yin, Too, & Chow, 2005).  
  Increased generation of ROS and oxidative stress were observed in SAEC upon 24-hour 
exposure to all treatments. Qualitatively, it was observed that AA4 exhibited the highest 
generation of ROS at 10 µg compared to the highest generation of ROS at 10 and 15 µg for S4. 
For 16HBE, the only prominent increase in ROS generation for rNPs occurred at the highest 
concentrations of AA4 and S4, which could indicate a higher generation of ROS exhibited by the 
darker shades. When comparing this data to the qualitative total glutathione (GSH) levels, AA4 
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exhibited much lower total GSH levels for SAEC than any other treatment, especially at the 
highest concentration, which could indicate that this cheaper, darker product generates more 
ROS. Oxidative stress due to exposure to pNPs (particularly metal oxides) has been documented 
to be a mechanism responsible for genotoxicity in vitro, which could provide evidence towards 
enhanced risk of oxidative stress and inflammation in African Americans, who might already 
have a higher rate of inflammation compared to Caucasians (Carroll et al., 2009; Charles et al., 
2018; Feairheller et al., 2011; Sharma et al., 2014; N. Singh, Jenkins, Asadi, & Doak, 2010; Xia 
et al., 2006; Zhang et al., 2012). Use of these products may have a more pronounced effect on 
African Americans’ health, in combination with SES differences, such as location, medical care, 
and accessibility of resources and stress (Williams, 2002; Williams, Priest, & Anderson, 2016). 
The effect from resulting oxidative stress caused by increased ROS in AA4 can be seen in the 
decreased cellular viability of SAEC of about 40% at the highest concentration, which is lower 
than the lighter shades. Oxidative stress effects were also observed from SAEC exposure to S4 
but had a 23-25% viability reduction in all but one treatment. However, S1 and S4 seemed to 
decrease viability in 16HBE at 20 µg, though not significantly, which could demonstrate that the 
expensive products may have had a different effect on the 16HBE cells. When comparing the 
pNPs to the rNPs, Fe2O3 and TiO2 both generated ROS, reduced total glutathione levels, and 
reduced cellular viability with increasing doses but not as much as the AA4 or some of the other 
doses of rNPs did, which indicates that rNPs may exert more toxic effects than pNPs based on 
the evidence of oxidative stress being associated with particle mediated toxicity observed in 
other studies (N. Li, Xia, & Nel, 2008; Manke, Wang, & Rojanasakul, 2013; A. Nel et al., 2006). 
EMT and western blot data was used to determine the loss of adherence and phenotypic 
changes in SAEC due to exposure to pNPs and rNPs. From these results, it was determined that 
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there was indication of EMT after exposure to Fe2O3 for 24 hours and 7 days, with more 
prominence in the latter exposure. This could suggest that more sub-chronic exposure to the 
pristine ENM powder could induce EMT, cellular response, and fibrotic changes, which may 
lead to adverse outcomes such as respiratory inflammation and asthma (Ijaz et al., 2014; 
Lambrecht & Hammad, 2012). Differences between EMT in AA4 and Fe2O3 could not be 
comparable, though the EMT data on Fe2O3 may be useful to occupational workers exposed to 
these pNP powders more frequently and in larger doses. To examine effects on EMT in the 
sensitive SAEC, western blot analysis was conducted on 3-week exposures and indicated that the 
AA8, S1, and S4 may induce EMT but further study is warranted to ensure results, possibly with 
introduction of other EMT-related proteins in airways, such as CD44 (Hackett et al., 2009). 
While this study may have provided some evidence towards differences in toxicity from 
rNPs and pNPs and how they can affect the susceptible populations, there are some limitations. 
One notable limitation was that static 2-D cell cultures were used, as opposed to in vivo methods. 
As a result, the data cannot be directly extrapolated to human risk but can provide a foundation 
in which to develop an in vivo experiment upon to get closer to identifying a realistic human risk 
when exposed to pNPs and rNPs in the air. Another limitation is that the dosimetry was not 
determined for each rNP. This is important as each rNP may not be delivering the same dose 
based on differences in dispersion and other characteristics unique to each rNP (Cohen et al., 
2013; Pal et al., 2014; Pal, Watson, et al., 2015; Pal, Bello, Cohen, & Demokritou, 2015). To 
ensure more accurate results, a dose-response relationship could be determined for each rNP 
incorporating in vitro dosimetry, especially when using cell types with different media. Another 
limitation is that only one-time point was used for cellular viability and oxidative stress assays, 
so by adding in more acute or sub-chronic time points, it may provide a broader picture to the 
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effects of these NEPs on pulmonary function. Finally, since 16HBE were not as much affected as 
the primary SAEC were, the doses administered to 16HBE could be increased until there is an 
effect observed.  
In summation, the desire to make cheaper and better products quicker will always be 
present in the minds of manufacturers and thus the use of ENMs will inevitably increase as 
nanotechnological techniques improve and chemical formulations are tweaked. As a result, this 
increased insertion of ENMs in products will likely rapidly increase the number of NEPs 
released into the marketplace globally as well as human and environmental exposure to these 
products. Thus, the importance of determining the toxicological effects of these products on 
human health is paramount in closing the gap in lack of knowledge and safely protecting present 
and future generations from adverse effects due to NEP exposure, especially since knowledge is 
limited on rNPs as compared to ambient or pNPs. This investigation provides evidence to 
conduct further studies regarding NEP exposure via more refined in vitro or in vivo 
methodologies.   
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TABLES 
 
 
 
Table 1. Summary of Engineered Nanomaterials and Nano-Enabled Products Utilized in Study 
ENM/NEP Name Pristine 
(pNP) 
Released 
(rNP) 
Light Shade Dark Shade Expensive Inexpensive 
Fe2O3 ✓  
 
N/A N/A N/A N/A 
TiO2 ✓  
 
N/A N/A N/A N/A 
AA4 
 
✓  
 
✓  
 
✓  
AA8 
 
✓  ✓  
  
✓  
S1 
 
✓  ✓  
 
✓  
 
S4 
 
✓  
 
✓  ✓  
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Table 5. Colloidal Characterization of Raw Products, Released 
Nanoparticles, and Pristine Nanoparticles Using Dynamic Light 
Scattering   
85 
FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Image of Aerosol Generation System Used to Collect 
Released Aerosolized Engineered Nanoparticles   
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Figure 2. Composition of Metals Present in Both Expensive and Inexpensive Cosmetic Lines 
Determined by Inductively Coupled Plasma Mass Spectrometry    
87 
AA4 – Average Concentration = 7.77 mg/m3 AA8 – Average Concentration = 6.40 mg/m3 
S4 – Average Concentration = 7.64 mg/m3 
Figure 3. Aerosol Generation System Real Time Exposure Measurements for Released 
Nanoparticles 
S1 – Average Concentration = 7.17 mg/m3 
88 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Scanning Mobility Particle Sizer Data for S4 
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Figure 5. Scanning Electron Microscope Images of Released Nanoparticles 
AA4 AA8 
S1 S4 
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Figure 6. Preliminary Fluorescent Detection of Reactive Oxygen 
Species for SAEC Exposed to Serial Dilutions of Released AA4 
Product for 24 Hours 
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